Provided by Tiger Trade Technology Pte. Ltd.

SBP GROUP

5.580
-0.130-2.28%
Volume:35.27M
Turnover:195.82M
Market Cap:104.25B
PE:36.73
High:5.630
Open:5.605
Low:5.440
Close:5.710
52wk High:8.335
52wk Low:4.136
Shares:18.68B
HK Float Shares:18.68B
Volume Ratio:0.58
T/O Rate:0.19%
Dividend:0.12
Dividend Rate:2.15%
EPS(LYR):0.152
ROE:14.07%
ROA:7.51%
PB:2.73
PE(LYR):36.73
PS:2.64

Loading ...

Sino Biopharmaceutical Stock Slides 1.2% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 07

Wuhan Dazhong Dental Proposes Wang Hong as Executive Director to Replace Guo Jiaping

Reuters
·
Sep 04

Sino Biopharma Gets US FDA Investigational New Drug Approval for Tumor Drug

MT Newswires Live
·
Sep 04

Sino Biopharm Says FDA Clears IND for Tqb6426 GPC3 ADC Trial in Advanced Tumors

Reuters
·
Sep 03

Sino Biopharmaceutical - Application for Clinical Trial on Tqb6426 "Gpc3 ADC" Approved by FDA

THOMSON REUTERS
·
Sep 03

Sino Biopharmaceutical Stock Rises 6.3% in Hong Kong, Outperforms Competitors

Dow Jones
·
Sep 03

SBP Group Surges Over 4% in Morning Trade on FDA Clearance for TQB6426

Deep News
·
Sep 03

Movement Alert|SBP GROUP Rises 3.33% in Regular Trading, Core ADC Drug TQB2102 Phase III Trial Hits Primary Endpoint

Market Focus
·
Sep 03

Sino Biopharm Files HKEX Next-Day Return Disclosing Share Buyback for Cancellation

Reuters
·
Sep 01

SBP Group Reports No Share Changes in August; 14.60 Million Shares Earmarked for Future M&A Payout

Bulletin Express
·
Sep 01

Sino Biopharma Unit Enters License, Supply Contract for Cancer Drug

MT Newswires Live
·
Aug 31

SBP Group inks exclusive pact with Cipla for novel HER2-targeting ADC

Stock News
·
Aug 31

Sino Biopharma Licenses HER2 ADC Tqb2102 to Cipla for India, South Africa, Other Emerging Markets in Deal Worth up to USD 123 Million

Reuters
·
Aug 31

Sino Biopharmaceutical - Cipla Granted Exclusive License for Tqb2102 in India, South Africa and Five Markets

THOMSON REUTERS
·
Aug 31

Sino Biopharmaceutical - Group Eligible for up to $123 Mln in Milestone Payments and Tiered Double-Digit Royalties

THOMSON REUTERS
·
Aug 31

Cipla and SBP Group Sign Exclusive Licensing Agreement for HER2 Bispecific Antibody-Drug Conjugate

Reuters
·
Aug 31

Sino Biopharmaceutical Stock Sheds 2.6% in Hong Kong

Dow Jones
·
Aug 31

Movement Alert|SBP GROUP Falls 3.04% in Regular Trading, Trading at HK$5.425

Market Focus
·
Aug 31

SBP Group Unveils Phase I Data: Single-Dose Kylo-11 Achieves Up to 97% Sustained Lp(a) Reduction

Bulletin Express
·
Aug 31

SBP Group Secures NMPA and FDA Green Lights for LM-364 “Nectin-4TME ADC” Clinical Trials

Bulletin Express
·
Aug 28